Skip to content

Bringing Precision Medicine to Market

  • June 10, 2019

When it comes to biopharmaceutical drug discovery and development, we live in an incredible time. The FDA has approved innovative medicines with differing approaches, platforms, technologies, and modalities. As we leverage new technologies, our strategies for drug discovery are leading to therapeutic diversity, which is rapidly becoming a complicated landscape for manufacturing teams.

In this eBook authored by Amit Bhatia, Anthony Reese, and Akhil Rachamadugu of Scimitar, Inc., learn how diverse therapies are creating complexity and how digital innovations are driving modernization in today’s biopharmaceutical landscape.

Topics covered:

  • Novel Technologies and Platforms
  • Every Patient is a “Batch”
  • What is Needed to Scale for Success?
  • Case Studies

 

RELATED NEWS

Soaring to New Heights: A Recap of the 2024 American Aerospace & Defense Summit

As the 2024 fall season came to a close, our team made its way to the scenic desert landscapes of Arizona for the 10th...

by Laura Sahr

Insight and Innovation: A Recap of the 2024 American Pharma Manufacturing & Outsourcing Summit

As part of our Fall Events Season, the team headed to Boston to host our American Pharma Manufacturing & Outsourcing...

by Laura Sahr

The Next Pit Stop: 9th Annual American Automotive Summit Recap Blog

Shifting Gears

The MGM Grand Detroit buzzed with energy on November 12-13, 2024, as the 9th Annual American Automotive...

by Clarissa Wong